Humalog Mix50 100unitsml suspension for injection 3ml cartridges Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

humalog mix50 100unitsml suspension for injection 3ml cartridges

eli lilly and company ltd - insulin lispro; insulin lispro protamine - suspension for injection - 50unit/1ml ; 50unit/1ml

Humalog Mix25 KwikPen 100unitsml suspension for injection 3ml pre-filled pen Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

humalog mix25 kwikpen 100unitsml suspension for injection 3ml pre-filled pen

eli lilly and company ltd - insulin lispro; insulin lispro protamine - suspension for injection - 25unit/1ml ; 75unit/1ml

Humalog Mix50 KwikPen 100unitsml suspension for injection 3ml pre-filled pen Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

humalog mix50 kwikpen 100unitsml suspension for injection 3ml pre-filled pen

eli lilly and company ltd - insulin lispro; insulin lispro protamine - suspension for injection - 50unit/1ml ; 50unit/1ml

Humalog Mix25 100unitsml suspension for injection 10ml vials Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

humalog mix25 100unitsml suspension for injection 10ml vials

eli lilly and company ltd - insulin lispro protamine; insulin lispro - suspension for injection - 75unit/1ml ; 25unit/1ml

Insulin lispro Sanofi Unjoni Ewropea - Ingliż - EMA (European Medicines Agency)

insulin lispro sanofi

sanofi winthrop industrie - insulin lispro - diabetes mellitus - drugs used in diabetes - for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. insulin lispro sanofi is also indicated for the initial stabilisation of diabetes mellitus.

Humalog Mix 50 Armenja - Ingliż - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

humalog mix 50

lilly france s.a.s. - 50% insulin lispro solution and 50% insulin lispro protamine suspension (recombinant dna) - suspension for s/c injection - 100iu/ml (3,5mg/ml)

VENOFER iron 100mg/5mL (as iron(III) hydroxide sucrose complex) injection Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

venofer iron 100mg/5ml (as iron(iii) hydroxide sucrose complex) injection

seqirus pty ltd - iron sucrose, quantity: 540 mg/ml (equivalent: iron, qty 20 mg/ml) - injection, concentrated - excipient ingredients: sodium hydroxide; water for injections - venofer is indicated for the treatment of iron deficiency anaemia in patients undergoing chronic haemodialysis and who are receiving supplemental erythropoietin therapy.,the diagnosis of iron deficiency must be based on appropriate laboratory tests (e.g. serum ferritin, serum iron, transferrin saturation and hypochromic red cells).